Search Within

Daniel Fontes Santos De Teive Argolo

Formats
  1. Meeting Abstract (6)
  2. Journal Article (3)
Groups
  1. Breast Medicine Service (9)
  2. Department of Medicine (9)
  3. Population Sciences Research Program (9)
  4. Solid Tumor Oncology Division (9)
  5. Survivorship Research (9)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (6)

More Groups

People
  1. Clifford Hudis (9)
  2. Neil Iyengar (8)
  3. Chau Dang (7)
  4. Larry Norton (6)
  5. Lillian Smyth (6)
  6. Jose Baselga (5)

More People

Years
  1. 2017 (1)
  2. 2016 (5)
  3. 2015 (3)
Publications
  1. Cancer Research (4)
  2. Journal of Clinical Oncology (3)
  3. Current Breast Cancer Reports (1)
  4. Indian Journal of Surgical Oncology (1)
Publishers
  1. American Association for Cancer Research (4)
  2. American Society of Clinical Oncology (3)
  3. Springer (1)
  4. Springer India (1)

Results (9)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II study of gemcitabine, trastuzumab, and pertuzumab for HER2-Positive metastatic breast cancer after prior pertuzumab-based therapy
    Meeting Abstract

    Iyengar, N. M.; Smyth, L.; Lake, D.; Gucalp, A.; Singh, J. C.; Traina, T. A.; DeFusco, P.; Dickler, M. N.; Fornier, M. N.; Goldfarb, S.; more...
    Cancer Research (2017)

    Fulltext@MSK | Save
  • Activity of HP-based therapies as third and later lines for the treatment of HER2-positive metastatic breast cancer: A retrospective study from a single institution
    Meeting Abstract

    Argolo, D.; Friedman, M.; Smyth, L.; Iyengar, N.; Singh, J.; Patil, S.; Norton, L.; Baselga, J.; Hudis, C.; Dang, C.
    Cancer Research (2016)

    Fulltext@MSK | Save
  • Phase II study of gemcitabine, trastuzumab, and pertuzumab in the treatment of metastatic HER2-positive breast cancer after prior trastuzumab/pertuzumab- or pertuzumab-based therapy
    Meeting Abstract

    Iyengar, N. M.; Argolo, D.; Smyth, L.; Chen, M. F.; Hudis, C. A.; Dang, C. T.
    Cancer Research (2016)

    Fulltext@MSK | Save
  • Pathologic complete response rate with doxorubicin and cyclophosphamide followed by weekly paclitaxel with trastuzumab and pertuzumab in patients with HER2-positive early stage breast cancer: A single institution experience
    Meeting Abstract

    Singh, J. C.; Sugarman, S.; Jones, L.; Boafo, C.; Patil, S.; Schweber, S.; Yu, A.; Argolo, D.; Modi, S.; Iyengar, N.; more...
    Cancer Research (2016)

    Fulltext@MSK | Save
  • Cardiac surveillance guidelines for trastuzumab-containing therapy in early-stage breast cancer: Getting to the heart of the matter
    Journal Article

    Dang, C. T.; Yu, A. F.; Jones, L. W.; Liu, J.; Steingart, R. M.; Argolo, D. F.; Norton, L.; Hudis, C. A.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Obesity and cancer - Opportunities to break the link
    Journal Article

    Argolo, D. F.; Hudis, C. A.; Iyengar, N. M.
    Current Breast Cancer Reports (2016)

    Fulltext@MSK | Save
  • Obesity and cancer: Concepts and challenges
    Journal Article

    Argolo, D. F.; Iyengar, N. M.; Hudis, C. A.
    Indian Journal of Surgical Oncology (2015)

    Fulltext@MSK | Save
  • Phase II study of weekly paclitaxel with trastuzumab and pertuzumab in patients with HER2-overexpressing metastatic breast cancer (MBC): Updated progression-free survival with overall survival result
    Meeting Abstract

    Smyth, L. M.; Iyengar, N. M.; Chandarlapaty, S.; Sugarman, S.; Comen, E. A.; Drullinsky, P.; Sklarin, N. T.; Traina, T. A.; Troso-Sandoval, T. A.; Patil, S.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Trastuzumab and pertuzumab-based versus other therapy as second-line therapy in HER2-positive metastatic breast cancer: A retrospective study from single center
    Meeting Abstract

    Fontes Santos De Teive Argolo, D.; Smyth, L. M.; Iyengar, N. M.; Patil, S.; Norton, L.; Baselga, J.; Hudis, C. A.; Dang, C. T.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save